The study, conducted at the virtual urgent care clinic Cedars-Sinai Connect in LA, compared recommendations given in about 500 visits of adult patients with relatively common symptoms – respiratory, urinary, eye, vaginal and dental.
A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations made by artificial intelligence (AI) and physicians at Cedars-Sinai Connect, a virtual urgent care clinic in Los Angeles, operated in collaboration with Israeli startup K Health. The paper was published in Annals of Internal Medicine and presented at the annual conference of the American College of Physicians (ACP). This work was supported with funding by K Health.
Prof. Zeltzer explains: “Cedars-Sinai operates a virtual urgent care clinic offering telemedical consultations with physicians specializing in family and emergency care. Recently, an AI system was integrated into the clinic algorithm based on machine learning that conducts initial intake through a dedicated chat, incorporates data from the patient’s medical record, and provides the attending physician with detailed diagnostic and treatment suggestions at the start of the visit -including prescriptions, tests, and referrals. After interacting with the algorithm, patients proceed to a video visit with a physician who ultimately determines the diagnosis and treatment. To ensure reliable AI recommendations, the algorithm-trained on medical records from millions of cases, only offers suggestions when its confidence level is high, giving no recommendation in about one out of five cases. In this study, we compared the quality of the AI system’s recommendations with the physicians’ actual decisions in the clinic.”
The researchers examined a sample of 461 online clinic visits over one month during the summer of 2024. The study focused on adult patients with relatively common symptoms-respiratory, urinary, eye, vaginal and dental. In all visits reviewed, the algorithm initially assessed patients, provided recommendations, and then treated them by a physician in a video consultation. Afterwards, all recommendations from both the algorithm and the physicians were evaluated by a panel of four doctors with at least ten years of clinical experience, who rated each recommendation on a four-point scale: optimal, reasonable, inadequate, or potentially harmful. The evaluators assessed the recommendations based on the patients’ medical histories, the information collected during the visit, and transcripts of the video consultations.
The compiled ratings led to interesting conclusions: AI recommendations were rated as optimal in 77% of cases, compared to only 67% of the physicians’ decisions; at the other end of the scale, AI recommendations were rated as potentially harmful in a smaller portion of cases than physicians’ decisions (2.8% of AI recommendations versus 4.6% of physicians’ decisions). In 68% of the cases, the AI and the physician received the same score; in 21% of cases, the algorithm scored higher than the physician; and in 11% of cases, the physician’s decision was considered better.
The explanations provided by the evaluators for the differences in ratings highlight several advantages of the AI system over human physicians: First, the AI more strictly adheres to medical association guidelines-for example, not prescribing antibiotics for a viral infection; second, AI more comprehensively identifies relevant information in the medical record-such as recurrent cases of a similar infection that may influence the appropriate course of treatment; and third, AI more precisely identifies symptoms that could indicate a more serious condition, such as eye pain reported by a contact lens wearer, which could signal an infection. On the other hand, physicians are more flexible than the algorithm and have an advantage in assessing the patient’s real condition. For example, suppose a COVID-19 patient reports shortness of breath. A doctor may recognize it as a relatively mild respiratory congestion in that case. In contrast, based solely on the patient’s answers, the AI might unnecessarily refer them to the emergency room.
Prof. Zeltzer concludes: “In this study, we found that AI, based on a targeted intake process, can provide diagnostic and treatment recommendations that are, in many cases, more accurate than those made by physicians. One limitation of the study is that we do not know which physicians reviewed the AI’s recommendations in the available chart, or to what extent they relied on these recommendations. Thus, the study only measured the accuracy of the algorithm’s recommendations and not their impact on the physicians. The study’s uniqueness lies in the fact that it tested the algorithm in a real-world setting with actual cases, while most studies focus on examples from certification exams or textbooks. The relatively common conditions included in our study represent about two-thirds of the clinic’s case volume. Thus, the findings can be meaningful for assessing AI’s readiness to serve as a decision-support tool in medical practice. We can envision a near future in which algorithms assist in an increasing portion of medical decisions, bringing certain data to the doctor’s attention, and facilitating faster decisions with fewer human errors. Of course, many questions still remain about the best way to implement AI in the diagnostic and treatment process, as well as the optimal integration between human expertise and artificial intelligence in medicine.”
Other authors involved in the study include Zehavi Kugler, MD; Lior Hayat, MD; Tamar Brufman, MD; Ran Ilan Ber, PhD; Keren Leibovich, PhD; Tom Beer, MSc; and Ilan Frank, MSc., Caroline Goldzweig, MD MSHS, and Joshua Pevnick, MD, MSHS.
- Dan Zeltzer, Zehavi Kugler, Lior Hayat, et al. Comparison of Initial Artificial Intelligence (AI) and Final Physician Recommendations in AI-Assisted Virtual Urgent Care Visits. Ann Intern Med. [Epub 4 April 2025]. doi:10.7326/ANNALS-24-03283, https://www.acpjournals.org/doi/10.7326/ANNALS-24-03283
News
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]















